Professor & Chair, Department of Bioengineering and Therapeutic Sciences, California Institute of Quantitative Biosciences
James Fraser studied Biology as an undergraduate at McGill University. His Ph.D. work at UC Berkeley under Dr. Tom Alber focused on the relationship between protein conformational dynamics and enzymatic catalysis. He moved to UCSF to start his lab in 2011. Currently, Professor Fraser is Chair of the Department of Bioengineering and Therapeutic Sciences. His lab’s work spans across various disciplines, including structural biology, deep mutational scanning, and drug discovery. He is also known for his commitment to open science, serving on the board of ASAPbio for many years. He recently started OpenADMET, an organization with the mission to build open predictive models of drug safety and toxicity to more reliably, cheaply, and effectively treat disease.